16alpha,17,21-Trihydroxypregna-1,4,9(11)-triene-3,20-dione 21-acetate
95%
- Product Code: 238485
CAS:
77017-20-0
| Molecular Weight: | 400.5 g./mol | Molecular Formula: | C₂₃H₂₈O₆ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
Used in the synthesis of corticosteroid intermediates for anti-inflammatory and immunosuppressive drugs. It serves as a key precursor in the production of high-potency steroids, particularly those used in treating skin conditions, asthma, and autoimmune disorders. Its structure allows for selective modification to enhance glucocorticoid activity while minimizing mineralocorticoid effects. Commonly employed in pharmaceutical research and development for optimizing steroid-based therapies.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | €518.52 |
+
-
|
16alpha,17,21-Trihydroxypregna-1,4,9(11)-triene-3,20-dione 21-acetate
Used in the synthesis of corticosteroid intermediates for anti-inflammatory and immunosuppressive drugs. It serves as a key precursor in the production of high-potency steroids, particularly those used in treating skin conditions, asthma, and autoimmune disorders. Its structure allows for selective modification to enhance glucocorticoid activity while minimizing mineralocorticoid effects. Commonly employed in pharmaceutical research and development for optimizing steroid-based therapies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
€0.00
€0.00
Total :